SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-028627
Filing Date
2023-06-16
Accepted
2023-06-16 16:27:23
Documents
17
Period of Report
2023-06-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K celu-20230614.htm   iXBRL 8-K 115952
2 EX-3.1 celu-ex3_1.htm EX-3.1 18546
3 GRAPHIC img237429923_0.jpg GRAPHIC 47927
4 GRAPHIC img237429923_1.jpg GRAPHIC 32536
5 GRAPHIC img237429923_2.jpg GRAPHIC 6994
  Complete submission text file 0000950170-23-028627.txt   419999

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT celu-20230614_lab.xml EX-101.LAB 18311
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celu-20230614.xsd EX-101.SCH 3461
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celu-20230614_pre.xml EX-101.PRE 14636
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celu-20230614_def.xml EX-101.DEF 14591
11 EXTRACTED XBRL INSTANCE DOCUMENT celu-20230614_htm.xml XML 6681
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 231021579
SIC: 2834 Pharmaceutical Preparations